Cord Blood America Inc. Reports Earnings Results for the First Quarter Ended March 31, 2016
May 16, 2016 at 06:36 pm IST
Share
Cord Blood America Inc. reported earnings results for the first quarter ended March 31, 2016. For the quarter, the company's total revenue was $0.99 million, a decrease of 22.7% from total revenue of $1.28 million for the first quarter 2015. The decrease in revenue is due primarily to a decrease in orders for the Company’s tissue procurement services. EBITDA was $0.08 million, a decrease of 62.2% from EBITDA of $0.21 million for the first quarter 2015. The company’s net loss was $0.008 million for the three month period ending March 31, 2016, compared to $0.21 million for the period ended March 31, 2015.
CBA Florida, Inc., formerly Cord Blood America, Inc., through its CorCell program and its subsidiary CorCell Companies, Inc., provides cord blood and cord tissue stem cell services. The Company's subsidiaries include Cord Partners, Inc., CorCell Companies, Inc., CorCell, Ltd., (Cord Partners, Inc., CorCell Companies, Inc. and CorCell, Ltd. are referred to collectively as Cord), CBA Properties, Inc. (Properties), and Career Channel, Inc. The Company and its subsidiaries provides private cord blood and cord tissue stem cell storage services to families throughout the United States and Puerto Rico, and Properties was formed to hold corporate trademarks and other intellectual property. Cord's operations provide umbilical cord blood banking and cord tissue services to expectant parents. Cord provides various services, which includes collection materials, physician and customer support, transportation, testing and cord blood storage.
CBA FLORIDA, INC. 
